Form 4: Natera Executive Vests 44,698 Shares

Natera's President of Clinical Diagnostics, Solomon Moshkevich, vested 44,698 shares of common stock on January 14, 2026, following the certification of a performance milestone.

Summary

• Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., acquired 44,698 shares of common stock.
• This acquisition occurred on January 14, 2026, through the vesting of a performance-based Restricted Stock Unit (RSU) award.
• The RSU award was originally granted on January 27, 2023, and vests in tranches based on time and specific business performance criteria.
• The vesting was triggered by the certification of a performance threshold related to one milestone.
• Following this transaction, Moshkevich beneficially owns 168,197 shares of Natera common stock directly.

Sentiment

Score: 6

Explanation: The vesting of performance-based RSUs for a key executive is a positive indicator that internal performance milestones have been met, aligning executive incentives with company success. While not directly impacting the company's operational or financial performance, it reflects positively on internal goal achievement.

Positives

• The vesting of 44,698 shares indicates the achievement of a business performance milestone, suggesting successful internal goal attainment.
• Increases the beneficial ownership of a key executive, further aligning management's interests with those of shareholders.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

This filing details a routine executive compensation event and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Positive, as it indicates the achievement of internal performance milestones and aligns executive interests with shareholder value.
• Employees: May signal successful internal goal attainment within the company.
• Management: Solomon Moshkevich's compensation increases, reflecting successful performance.

Key Dates

Keywords

Natera, NTRA, Solomon Moshkevich, Form 4, SEC Filing, Restricted Stock Units, RSU, Stock Vesting, Executive Compensation, Insider Transaction, Common Stock